Both in Pharmaceuticals
iBio vs Pliant Therapeutics
Over the past year IBIO returned −47.7% and PLRX returned −47.1%; their daily moves had a correlation of 0.20.
IBIO −47.7% PLRX −47.1%Growth of $1, one year, split-adjusted
| Metric | IBIO | PLRX |
|---|---|---|
| Price | $0.8000 | $0.8518 |
| Market cap | $51.4M | $52.7M |
| Today | −2.85% | −1.03% |
| 1 month | −23.8% | −17.3% |
| 6 months | −54.8% | −30.7% |
| Year to date | −58.5% | −30.2% |
| 1 year | −54.5% | −49.0% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 514.5× | — |
| Net cash | $88.0M | $158.1M |
| Dividend yield | — | — |
| Volatility (60d) | 65.6% | 50.5% |
| Short % of float | 6.8% | 9.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).